Consult with your doctor about study participation.
Share your results and the study information with your doctor.
Age 18 or older
Have a confirmed diagnosis of chronic primary ITP
Have tried at least two ITP therapies that have not worked or stopped working
For your doctor: Description of the Meza ITP study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of an Investigational Study Drug in Participants with Chronic Primary Immune Thrombocytopenia
clinicaltrials.gov listing: NCT06722235
This website is intended only for residents of Australia.
TAK-079-3002_Meza ITP_Patient Website_V2.0_29 OCTOBER 2025_AUS